HighlightsWe provide a clear methodology for the assessment of validity, reliability and quality of life (QoL) instruments.Few authors of publications containing a QoL instrument define quality of life.Few of the instruments published for the assessment of QoL in dogs are validated.The quality of validated instruments for the assessment of QoL in dogs is variable.

Widespread media reports suggest that unusually high numbers of the public purchased, or sought to purchase, puppies following the first ‘lockdown’ phase of the COVID-19 pandemic in the UK, dubbed “Pandemic Puppies”. This study aimed to explore this phenomenon by comparing pre-purchase motivations and behaviours, and purchase behaviours of UK owners purchasing puppies aged < 16 weeks from 23 March 2020–31 December 2020 with those of owners who purchased puppies during the same date-period in 2019. An online survey was conducted during November-December 2020, from which 5517 valid responses were analysed (2019 puppies: n = 1148; 2020 ‘Pandemic Puppies’: n = 4369). Over 1 in 10 Pandemic Puppy owners had not considered purchasing a puppy before the pandemic, and 2 in 5 felt their decision to purchase a puppy had been influenced by the pandemic, most commonly by having more time to care for a dog (86.7%). Multivariable logistic regression models revealed that Pandemic Puppy owners were more likely to be first-time dog owners and have children in their household, were less likely to seek out a breeder that performed health testing on their breeding dog(s) or view their puppy in-person, and were more likely to pay a deposit without seeing their puppy. At purchase, Pandemic Puppies were more likely to be younger, delivered or collected from outside their breeders’ property, seen without their littermates, and cost > £2000 compared with 2019 puppies. Changes in puppy purchasing during the pandemic raise welfare concerns for this unique population, including relinquishment, behavioural problems and poor health.

HighlightsMany dogs with osteoarthritis receive NSAIDs for long time periods.The risk of NSAID-related adverse events concerns veterinary surgeons and dog owners.Many strategies are adopted to minimise the risk of these adverse events.These strategies may compromise animal welfare through inadequate analgesia.The evidence base to support these strategies is inadequate and should be addressed.

The expression of cyclooxygenase isoform 2 (COX-2) in canine nasal carcinomas has been well documented. COX-2 expression has proven to be a prognostic factor in several human tumours. The aims of this study were to assess the correlation between immunohistochemical COX-2 expression and prognosis using rhinoscopic biopsies from 42 dogs with nasal carcinomas treated with hypofractionated radiotherapy, and to establish a replicable COX-2 scoring system. Ninety per cent of sections evaluated were COX-2 positive with a mean score of 6.6 (median 8.0; range 0-12). Neither COX-2 expression nor tumour type had a significant correlation with survival. There are likely to be many as yet unidentified variants which contribute to length of survival in dogs with nasal carcinomas. Immunohistochemical COX-2 expression appears unlikely to be of prognostic significance for canine nasal carcinoma.